Morepen Labs.

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE083A01026
NSEID: MOREPENLAB
BSEID: 500288

INR

50.25

2.13 (4.43%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 31.04 lacs

{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "50.25",
    "chg": 2.13,
    "chgp": "4.43%",
    "dir": 1,
    "prev_price": "48.12",
    "mcapval": "2,753.47 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE083A01026",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:11 AM",
    "bse_nse_vol": "31.04 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/morepen-labs-546345-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Morepen Laboratories Sees Surge in Trading Volume and Investor Participation",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-records-high-trading-volume-and-significant-stock-performance-gains-1461595",
        "imagepath": "",
        "date": "2025-03-19 10:00:11",
        "description": "Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has emerged as one of the most active stocks today, with a total traded volume of 30,628,625 shares and a traded value of approximately Rs 1,468.95 crore. The stock opened at Rs 43.97 and reached a day high of Rs 50.50, closing at Rs 48.28, reflecting a 1.92% increase for the day. \n\nOver the past two days, Morepen Laboratories has shown a notable upward trend, gaining 16.25% in returns. The stock has outperformed its sector by 3.11%, indicating strong relative performance. Additionally, the delivery volume on March 18 reached 58.42 lakh shares, marking a significant increase of 254.73% compared to the five-day average delivery volume, suggesting rising investor participation.\n\nIn terms of moving averages, the stock is currently above its 5-day and 20-day averages but remains below the 50-day, 100-day, and 200-day averages...."
      },
      {
        "title": "Morepen Laboratories Sees Surge in Trading Volume Amid Market Sentiment Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-records-high-trading-volume-and-notable-stock-performance-on-march-18-3-1427624",
        "imagepath": "",
        "date": "2025-03-18 11:00:05",
        "description": "Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has emerged as one of the most active equities by volume today. The stock, trading under the symbol MOREPENLAB, saw a total traded volume of 5,993,086 shares, with a total traded value of approximately Rs 27.44 crore. \n\nOpening at Rs 43.97, Morepen Laboratories experienced a notable gain of 2.64% at the start of the trading session. The stock reached an intraday high of Rs 47.75, reflecting an increase of 11.46% during the day. This performance marks a significant trend reversal, as the stock has gained after five consecutive days of decline. \n\nIn terms of performance metrics, Morepen Laboratories outperformed its sector by 8.97%, with a one-day return of 10.41%. The stock's liquidity remains robust, with a delivery volume of 193,200 shares on March 17, which is up 27.57% compared to the five-day average. \n\nOverall, Morepe..."
      },
      {
        "title": "Morepen Laboratories Shows Potential Trend Reversal Amid Broader Market Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-gains-9-35-amid-positive-market-conditions-and-trend-reversal-1425757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/MorepenLaborato_priceRelatedfactors_684157.png",
        "date": "2025-03-18 09:35:22",
        "description": "Morepen Laboratories experienced notable activity, gaining 9.35% after a series of declines. The stock outperformed its sector and opened positively, reflecting resilience despite recent volatility. While it remains below several key moving averages, its long-term performance shows significant growth over the past five years."
      },
      {
        "title": "Morepen Laboratories Faces Year-to-Date Challenges Amid Broader Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-reports-32-61-year-to-date-decline-amid-market-challenges-1066642",
        "imagepath": "",
        "date": "2025-02-20 11:57:09",
        "description": "Morepen Laboratories, a small-cap player in the Pharmaceuticals & Drugs sector, has shown notable activity today with a 1.68% increase in its stock price, contrasting with a slight decline in the Sensex, which fell by 0.29%. Despite this daily uptick, the company's performance over the past month has been challenging, with a decline of 25.63%, significantly underperforming the Sensex's drop of 1.76%.\n\nThe company's market capitalization stands at Rs 2,863.00 crore, and it currently has a price-to-earnings (P/E) ratio of 22.57, which is below the industry average of 36.44. Over the past year, Morepen Laboratories has experienced a decline of 2.60%, while the Sensex has gained 3.64%. \n\nIn terms of technical indicators, the weekly MACD is bearish, while the monthly MACD shows bullish tendencies. Moving averages indicate a bearish trend on a daily basis. Overall, Morepen Laboratories has faced a challenging yea..."
      },
      {
        "title": "Morepen Laboratories Faces Continued Stock Decline Amid Sector Weakness in February 2025",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-7-06-amid-ongoing-seven-day-decline-in-february-2025-1012862",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MorepenLaborato_priceRelatedfactors_450089.png",
        "date": "2025-02-14 14:16:02",
        "description": "Morepen Laboratories has faced a notable decline in its stock price, dropping significantly today and continuing a downward trend over the past week. The stock is currently trading below multiple moving averages, indicating a bearish performance, and has underperformed compared to both its sector and the broader market."
      },
      {
        "title": "Morepen Laboratories Faces Financial Challenges Amidst Flat Quarterly Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-reports-18-7-decline-in-q3-fy24-25-profit-after-tax-961783",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MorepenLaborato_mojoScore_410244.png",
        "date": "2025-02-11 18:00:32",
        "description": "Morepen Laboratories has recently experienced a change in evaluation amid flat financial performance for the quarter ending December 2024. The company reported a decline in profit after tax and operating profit metrics, while maintaining a low debt-to-equity ratio. Valuation metrics suggest an attractive position relative to historical averages."
      },
      {
        "title": "Morepen Laboratories Reports Mixed Financial Results Amid Operational Challenges for Q4 2024",
        "link": "https://www.marketsmojo.com/news/result-analysis/morepen-laboratories-reports-flat-q3-fy24-25-performance-with-declining-profit-metrics-768641",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MorepenLaborato_quaterlyResult_384995.png",
        "date": "2025-02-06 17:23:54",
        "description": "Morepen Laboratories recently released its financial results for the quarter ending December 2024, showcasing a strong Debtors Turnover Ratio but facing challenges with declining Profit Before Tax and Profit After Tax. The company also reported lower Operating Profit and Earnings per Share, indicating a complex financial situation."
      }
    ],
    "total": 84,
    "sid": "546345",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "01-Apr-2025",
      "details": "Please find enclosed press release titled Morepen secured Loratadine approval for export to China.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "01-Apr-2025",
      "details": "Please find enclosed press release titled Morepen secured Loratadine approval for export to China.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "31-Mar-2025",
      "details": "Acquisition of Common Stock by Morepen Bio Inc. a Wholly owned subsidiary",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Morepen Laboratories Sees Surge in Trading Volume and Investor Participation

2025-03-19 10:00:11

Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has emerged as one of the most active stocks today, with a total traded volume of 30,628,625 shares and a traded value of approximately Rs 1,468.95 crore. The stock opened at Rs 43.97 and reached a day high of Rs 50.50, closing at Rs 48.28, reflecting a 1.92% increase for the day. Over the past two days, Morepen Laboratories has shown a notable upward trend, gaining 16.25% in returns. The stock has outperformed its sector by 3.11%, indicating strong relative performance. Additionally, the delivery volume on March 18 reached 58.42 lakh shares, marking a significant increase of 254.73% compared to the five-day average delivery volume, suggesting rising investor participation. In terms of moving averages, the stock is currently above its 5-day and 20-day averages but remains below the 50-day, 100-day, and 200-day averages....

Morepen Laboratories Sees Surge in Trading Volume Amid Market Sentiment Shift

2025-03-18 11:00:05

Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has emerged as one of the most active equities by volume today. The stock, trading under the symbol MOREPENLAB, saw a total traded volume of 5,993,086 shares, with a total traded value of approximately Rs 27.44 crore. Opening at Rs 43.97, Morepen Laboratories experienced a notable gain of 2.64% at the start of the trading session. The stock reached an intraday high of Rs 47.75, reflecting an increase of 11.46% during the day. This performance marks a significant trend reversal, as the stock has gained after five consecutive days of decline. In terms of performance metrics, Morepen Laboratories outperformed its sector by 8.97%, with a one-day return of 10.41%. The stock's liquidity remains robust, with a delivery volume of 193,200 shares on March 17, which is up 27.57% compared to the five-day average. Overall, Morepe...

Morepen Laboratories Shows Potential Trend Reversal Amid Broader Market Gains

2025-03-18 09:35:22

Morepen Laboratories experienced notable activity, gaining 9.35% after a series of declines. The stock outperformed its sector and opened positively, reflecting resilience despite recent volatility. While it remains below several key moving averages, its long-term performance shows significant growth over the past five years.

Morepen Laboratories Faces Year-to-Date Challenges Amid Broader Market Trends

2025-02-20 11:57:09

Morepen Laboratories, a small-cap player in the Pharmaceuticals & Drugs sector, has shown notable activity today with a 1.68% increase in its stock price, contrasting with a slight decline in the Sensex, which fell by 0.29%. Despite this daily uptick, the company's performance over the past month has been challenging, with a decline of 25.63%, significantly underperforming the Sensex's drop of 1.76%. The company's market capitalization stands at Rs 2,863.00 crore, and it currently has a price-to-earnings (P/E) ratio of 22.57, which is below the industry average of 36.44. Over the past year, Morepen Laboratories has experienced a decline of 2.60%, while the Sensex has gained 3.64%. In terms of technical indicators, the weekly MACD is bearish, while the monthly MACD shows bullish tendencies. Moving averages indicate a bearish trend on a daily basis. Overall, Morepen Laboratories has faced a challenging yea...

Morepen Laboratories Faces Continued Stock Decline Amid Sector Weakness in February 2025

2025-02-14 14:16:02

Morepen Laboratories has faced a notable decline in its stock price, dropping significantly today and continuing a downward trend over the past week. The stock is currently trading below multiple moving averages, indicating a bearish performance, and has underperformed compared to both its sector and the broader market.

Morepen Laboratories Faces Financial Challenges Amidst Flat Quarterly Performance

2025-02-11 18:00:32

Morepen Laboratories has recently experienced a change in evaluation amid flat financial performance for the quarter ending December 2024. The company reported a decline in profit after tax and operating profit metrics, while maintaining a low debt-to-equity ratio. Valuation metrics suggest an attractive position relative to historical averages.

Morepen Laboratories Reports Mixed Financial Results Amid Operational Challenges for Q4 2024

2025-02-06 17:23:54

Morepen Laboratories recently released its financial results for the quarter ending December 2024, showcasing a strong Debtors Turnover Ratio but facing challenges with declining Profit Before Tax and Profit After Tax. The company also reported lower Operating Profit and Earnings per Share, indicating a complex financial situation.